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Abstract: Phosphatidylinositol-3-phosphate (PtdIns(3)P) is essential for cell survival, and its intra-
cellular synthesis is spatially and temporally regulated. It has major roles in two distinctive cellular 
pathways, namely, the autophagy and endocytic pathways. PtdIns(3)P is synthesized from phos-
phatidylinositol (PtdIns) by PIK3C3C/VPS34 in mammals or Vps34 in yeast. Pathway-specific 
VPS34/Vps34 activity is the consequence of the enzyme being incorporated into two mutually ex-
clusive complexes: complex I for autophagy, composed of VPS34/Vps34–Vps15/Vps15-Beclin 
1/Vps30-ATG14L/Atg14 (mammals/yeast), and complex II for endocytic pathways, in which 
ATG14L/Atg14 is replaced with UVRAG/Vps38 (mammals/yeast). Because of its involvement in au-
tophagy, defects in which are closely associated with human diseases such as cancer and neuro-
degenerative diseases, developing highly selective drugs that target specific VPS34/Vps34 com-
plexes is an essential goal in the autophagy field. Recent studies on the activation mechanisms of 
VPS34/Vps34 complexes have revealed that a variety of factors, including conformational changes, 
lipid physicochemical parameters, upstream regulators, and downstream effectors, greatly influ-
ence the activity of these complexes. This review summarizes and highlights each of these influences 
as well as clarifying key questions remaining in the field and outlining future perspectives. 




Phosphoinositides are phosphorylated forms of phosphatidylinositol (PtdIns). Phos-
phorylation takes place in one of the -OH groups of the inositol ring of PtdIns, which 
allows seven phosphoinositide species (three mono phosphates, three biphosphates, and 
one triphosphate) to occur. Although they exist at low abundance in the cell, their spatio-
temporal regulation is vital for cell signalling, membrane traffic, and metabolic processes 
[1]. Among these lipids, phosphorylation at the 3-OH position is executed by phospho-
inositide 3-kinases (PI3Ks). Based on their structures and substrate specificity, PI3Ks are 
divided into three classes, I, II, and III [2] (Figure 1). Class I PI3Ks have catalytic subunits 
p110α, p110β, p110γ, and p110δ and are encoded by the PIK3CA, PIK3CB, PIK3CG and 
PIK3CD genes, respectively. Class I enzymes synthesize PtsIns(3,4,5)P3 from PtdIns(4,5)P2 
and are mostly active on the plasma membrane (PM) [2], although recent studies revealed 
that they also can be found on endosomal compartments [3,4]. By interacting with their 
regulatory subunits, they have important roles in signalling downstream of GPCRs and 
receptor tyrosine kinases [5]. Class II PI3Ks (PIK3C2α, PIK3C2β, and PIKC2γ, encoded by 
the PIK3C2A, PIK3C2B, and PIK3C2C genes, respectively) synthesize PtdIns(3,4)P2 from 
PtdIns(4)P [2,6,7], and have a minor contribution to PtdIns(3)P synthesis from PtdIns 
[2,8,9]. Class II PI3Ks can be found alone without a regulatory subunit in various com-
partments, including the plasma membrane, recycling endosomes [10], and late endo-
somes/lysosomes [6]. Class III has a sole member, VPS34/Vps34 (mammals/yeast), which 
synthesizes PtdIns(3)P from PtdIns. VPS34/Vps34 is the most ancestral PI3K, found in 
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yeast and plants [11,12], whereas Class I and Class II PI3Ks can be found only in metazo-
ans [2]. The VPS34 gene was originally found in yeast (S. cerevisiae) by the Emr group as a 
gene in which mutations caused defects in the sorting of soluble vacuolar proteases but 
did not affect vacuolar morphology (“Class A” vpt (vacuole protein target) mutants) 
[13,14]. It is noteworthy that the VPS15 gene was also found in the same screen and cate-
gorized in the same class [13]. Later, it was confirmed that these two genes and gene prod-
ucts functionally and physically interact [15,16]. The next breakthrough from the Ohsumi 
laboratory revealed that yeast Vps34 and Vps15 are part of two mutually exclusive com-
plexes: complex I, composed of Vps34-Vps15-Vps30-Atg14, and complex II, composed of 
Vps34-Vps15-Vps30-Vps38 [17]. This one-subunit difference between the two complexes 
localizes them to different compartments, with complex I on the autophagosome, a dou-
ble-membrane structure generated during starvation, and complex II on endosomal com-
partments. Later, orthologous mammalian complex I, composed of VPS34-VPS15-Beclin 
1-ATG14L/Barkor [18–21], and complex II, composed of VPS34-VPS15-Beclin 1-UVRAG 
[18,20,22], were identified, indicating that not only the VPS34/Vps34 kinase subunit but 
whole heterotetrameric assemblies are conserved through evolution. As described below, 
each domain in the subunit of the complexes has a role in the assembly of the complex, 
interaction with lipids, or recruiting protein(s). These conserved heterotetrameric assem-
blies appear to be important not only for their localization, but also for efficient activation 
of the complexes. For example, the yeast Vps34–Vps15 heterodimer is less active than the 
yeast complexes I and II [23]. Also, human VPS34 alone is much less active than human 
complexes I and II [24]. These observations indicate that the heterotetrameric assembly is 
a minimal unit necessary for the full activation of VPS34/Vps34. The net activity of the 
complex is greatly influenced by conformational changes of the complex, upstream regu-
lators, surrounding lipid environments, and feedback mechanisms from the downstream 
effectors. This review aims at summarizing the recent progress from studies of the activa-
tion mechanisms of VPS34/Vps34 complexes. 




Figure 1. The class III PI3K VPS34/Vps34 is the most ancestral PI3K among the three classes of PI3Ks. 
The Class I PI3Ks phosphorylate PtdIns(4,5)P2 to synthesize PtdIns(3,4,5)P3, while the Class II PI3Ks 
phosphorylate PtdIns or PtdIns(4)P to synthesize PtdIns(3)P or PtdIns(3,4)P2, respectively. The Class 
III PI3K (PIK3C3 or VPS34/Vps34 for metazoans/yeast) phosphorylates PtdIns to synthesize 
PtdIns(3)P. This phylogenetic tree was generated using MEGA (https://www.megasoftware.net/). 
The following proteins, listed with their Uniprot entry numbers, were used for the analysis: p110α 
(Human: P42336; Mouse: P42337; Zebrafish: F1QAD7; Xenopus: F6VXG1); p110β (Human: P42338; 
Mouse: Q8BTI9; Zebrafish: E7F251); p110γ (Human: O00329; Mouse: O35904; Zebrafish: F1RB17); 
p110δ (Human:P48736; Mouse: Q9JHG7; Zebrafish: Q6NTI2; Xenopus: A0A6I8RLG9); PIK3C2α 
(Human: O00443; Mouse: Q61194; Zebrafish: F6NMW9; Xenopus: B5DE87); PIK3C2β (Human: 
O00750; Mouse: E9QAN8; Zebrafish: F1QWN6); PIK3C2γ (Human: O75747; Mouse: O70167; 
Zebrafish: A0A0G2L6J0); and PIK3C3/VPS34 (Human: Q8NEB9; Mouse: Q6PF93; Zebrafish: 
F1Q9F3; Xenopus: F6ZM84; Yeast Vps34: P22543). 
2. Basic Architectures of VPS34/Vps34 Complexes I and II 
VPS34/Vps34, Vps15/Vps15, and Beclin 1/Vps30 (metazoans/yeast) are common sub-
units between complexes I and II, whereas ATG14L/Atg14 is complex I-specific and 
UVRAG/Vps38 is complex II-specific (Figure 2A). Because three of four subunits are 
shared between them, the structures of complex I and complex II have similar shapes, 
described as V-shaped or Y-shaped [23,25] (Figure 2B), with VPS34/Vps34-VPS15/Vps15 
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UVRAG/Vps38 on the other arm (the adaptor or regulatory arm) (Figure 2B). Recent pro-
gress in structural studies has revealed the role of each domain of each subunit in com-
plexes I and II in the assembly and activation of the complexes. This is summarized in 
Figure 2A. For both complexes, the C2 domain of VPS34/Vps34 is located at the centre of 
the assemblies and serves as a structural hub that is unlikely to bind to membranes [23,25] 
(Figure 2B). The adaptor arms for both complexes are responsible for membrane binding 
and are essential for activation, although detailed features of the membrane-binding 
mechanisms appear to be different: complex I relies on the BATS domain in ATG14L 
[24,26–28], while complex II relies on the three motifs (aromatic fingers 1 and 2 and the 
hydrophobic loop) in Beclin 1/Vps30 [24,29–31]. Another important aspect is that the ki-
nase domain of VPS34/Vps34 is autoinhibited by the kinase domain of VPS15/Vps15 
[23,31,32]. It must be noted that except for its autophosphorylation in yeast [33], there has 
not been any VPS15/Vps15 substrate reported; therefore, whether VPS15/Vps15 is a more 
general protein kinase or not still remains elusive. 




Figure 2. The role of each domain of VPS34/Vps34 complex I and II subunits in the assembly of the complexes. (A) Sche-
matic representations of subunits in human numbers. (B) Structural schematic representations of complexes I and II. C2: 
C2 domain; CC: coiled-coil; BARA: β-α repeated, autophagy-specific (BARA) domain; BATS: Barkor/Atg14(L) autopha-
gosome targeting sequence (BATS) domain; NTD: N terminal domain; CTD: C terminal domain; CXXCs: CXXC motifs; 
WD40: WD40 domain; PR: proline-rich domain; BH3: BH3 domain. The figures are modified from [34,35]. 
3. Activation Mechanisms of VPS34/Vps34 and Complexes I and II 
(B)
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3.1. Basic Architecture of the VPS34 Kinase Domain 
Like other protein/lipid kinases, the kinase domain of VPS34/Vps34 is composed of 
N- and C-lobes, which are connected by a hinge region. ATP binds to a small pocket be-
tween these lobes (Figure 3A). The hinge is less conserved among PI3Ks, and the ATP-
binding pocket of VPS34 is somewhat smaller than those of other PI3Ks. By using these 
VPS34-specific characteristics of the kinase domain, recent VPS34-specific inhibitors were 
designed to target the ATP-binding pocket [35–40] (Figure 3A). Also, the VPS34 kinase 
domain has common features for activity, the P-loop, activation loop, and catalytic loop 
(Figure 3B). The P-loop binds to phosphates of ATP, while the activation loop binds to the 
lipid substrate PtdIns [41]. In contrast to the other class I PI3Ks that have largely disor-
dered activation loops in the structures of the wildtype enzymes, VPS34 has a completely 
ordered activation loop [41]. At the beginning of the activation loop, there is a highly con-
served DFG motif, which is important for transferring the phosphate by binding metal 
ions. Point mutations in this motif abolish the kinase activity of the mouse VPS34 [42]. The 
catalytic loop of VPS34 has a conserved DHR motif whereby the gamma phosphate of 
ATP is transferred to the substrate PtdIns. 
3.2. Activation Mechanisms of VPS34/Vps34 Complexes I and II 
Complex II is recruited to early endosomes and activated there by an early endo-
some-residing small GTPase, Rab5 [31,43–45] (Figure 3B), which results in PtdIns(3)P en-
richment in early endosomes [46,47]. While this recruitment and activation had been long 
known in the cell, the underlying mechanism was finally revealed recently using electron 
cryotomography (cryo-ET), hydrogen–deuterium exchange mass spectrometry (HDX-
MS), and unnatural amino acid (UAA)-mediated cross-linking [31]. Without Rab5, com-
plex II lies in an inactive state in which the VPS34 kinase domain is autoinhibited by the 
VPS15 kinase domain. Then, GTP-bound Rab5a recruits complex II to membranes mainly 
by binding to the C2 helical hairpin (C2HH) insertion in the C2 domain of VPS34. This 
Rab5a binding has a dual role: first, to recruit complex II to membranes, and second, to 
release the inhibition of the VPS15-mediated VPS34 kinase domain (Figure 3B middle). 
Membrane-bound complex II is still flexible enough to be able to transiently move the 
catalytic arm up and down to synthesize PtdIns(3)P from PtdIns (Figure 3B right). In con-
trast to human complex I (see below), this Rab5a binding does not appear to cause a dis-
lodging effect of the VPS34 kinase domain, indicating that the activation mechanism can 
be different depending on the complexes or their binding proteins [48]. The same study 
also found a new interaction between complex I and Rab1a and showed that membrane-
immobilized Rab1a greatly increased complex I activity [31] (Figure 3C, left). Interest-
ingly, GTP-bound Rab1a also binds to the VPS34 C2HH, the same region that complex II’s 
VPS34 uses to interact with Rab5a. Nonetheless, Rab1a specifically activates complex I 
[31]. The detailed activation mechanism of complex I by Rab1a remains to be seen in the 
future. It must be noted that in Tremel et al. [31], the complex I–Rab1a interaction was 
detected and examined in rich-medium conditions. In the cell, there is evidence for the 
involvement of Rab1/Ypt1 in autophagy during starvation. In yeast, Ypt1 binds to Atg11 
[49], Atg1 [50], and the autophagy-specific TRAPPIII complex, which is a GEF for Ypt1 
[50,51]. Human Rab1 also binds to ULK1 [50]. Also, in both yeast and mammals, 
Rab1/Ypt1 was immunoisolated from ATG9/Atg9 vesicles [52,53]. The localization of 
yeast Ypt1 to the PAS was dependent on Atg9 and TRAPIII [52], and the association of 
Rab1 with ATG9 vesicles was independent of ATG14L [53]. While all of these studies 
showed the association of Rab1/Ypt1 with either the ULK1/Atg1 complex or ATG9/Atg9 
vesicles, how Rab1/Ypt1 regulates complex I during autophagy/starvation remains to be 
seen. For human complex I, a negative stain EM analysis showed that 13% of particles 
lacked density for the HELical-CATalytic region (HELCAT) of VPS34 [32,41]. The authors 
hypothesized that this highly mobile HELCAT (“dislodging”) could be the key for the 
activity of the complex. However, the same group later reported different structures of 
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VPS34 complex I at higher resolutions using cryo-EM. Only the VPS34 kinase domain was 
mobile in apo complex I and in complex I in the presence of the complex I-specific binding 
subunit NRBF2 [48] (Figure 3C right; for NRBF2, see below). No dislodging effect of the 
HELCAT was found in this study, and the authors speculated that dislodging is an inter-
mediate state [48]. Using the autoinhibition information, Steinfeld et al. designed active 
mutants for the yeast Vps34–Vps15 heterodimer by introducing point mutations at an in-
terface between the Vps34 HELCAT and Vps15 kinase domain [54]. Unlike in human com-
plex I, the kinase domains of Vps34 and Vps15 are tightly packed in the yeast Vps34–
Vps15 heterodimer [55]. Also, the yeast Vps34–Vps15 heterodimer is not active on flat 
membranes and much less active on small (100 nm) vesicles than the yeast complexes I 
and II [23]. This indicates that the yeast Vps34–Vps15 might not be active because of the 
tight packing between the kinase domains of Vps34 and Vps15, which might be somehow 
relaxed by having full assemblies in heterotetrameric complexes. 




Figure 3. Activation mechanisms of VPS34/Vps34 complexes. (A) Schematic representations of the VPS34/Vp34 kinase 
domain. Left: A simplified structure of the kinase domain. An ATP molecule is sandwiched by the N- and C-lobes, which 
are connected by the hinge region. Right: A schematic representation of the kinase domain in human VPS34, modified 
from [35]. Residue numbering shown is for the human VPS34. (B) The activation mechanism of human complex II by 
Rab5a. Left: Complex II is recruited in an autoinhibition form to early endosomes by the early endosome specific small 
GTPase Rab5a in a GTP-dependent manner. Middle: The Rab5a binding not only recruits complex II to the membrane but 
releases the VPS34 kinase domain from autoinhibition by the VPS15 kinase domain. Rab5a binds mainly to the C2 helical 
hairpin insertion (C2HH) of VPS34, along with the small globular domain (SGD) and WD40 domain in VPS15. Along with 
Rab5a, three motifs in the Beclin 1 BARA domain are responsible for the membrane binding. Right: The membrane-an-
chored active complex II can tilt up and down to phosphorylate PtdIns and synthesize PtdIns(3)P. (C) Activation mecha-
nisms of complex I. In addition to the Beclin 1 aromatic finger 1, the ATG14L BATS domain is essential for the membrane 
anchoring of complex I. Left: Complex I activation by Rab1a. GTP-bound Rab1a binds to the same C2HH in VPS34 as 





P-loop (612–618; ATP phosphates binding) Activation loop (761–780; PtdIns binding)
533 887
(A)
Catalytic loop (740–748; transferring ATP gamma phosphate to PtdIns)  
C-lobe
Complex I activation by NRBF2
Complex II activation by Rab5a









































Cells 2021, 10, 3124 9 of 38 
 
 
4. Controlling the Intracellular PtdIns(3)P Concentration 
In yeast, vps34∆ and vps15∆ mutants showed temperature sensitivity in the SEY6210 
strain [14,15]. Knockout mice lacking the PIK3C3 (encoding VPS34), PIK3R4 (encoding 
VPS15), and BECN1 (encoding Beclin 1) genes were all embryonically lethal [56–59], indi-
cating that PtdIns(3)P is essential for cell survival and intracellular homeostasis of yeast 
and mammals. 
PtdIns(3)P distribution on the autophagosomal membranes is different between 
yeast and mammals. In yeast, PtdIns(3)P was more abundant on the luminal side than the 
cytoplasmic side, whereas in mammals, PtdIns(3)P was predominantly detected on the 
cytoplasmic side of the autophagosome [60]. Because the asymmetrical distribution of 
PtdIns(3)P in yeast can be partially recovered by PtdIns(3)P phosphatase mutations [60], 
it appears that in yeast, the PtdIns(3)P on the cytoplasmic side of the autophagosome is 
quickly metabolized into PtdIns. Consistently with this, autophagy is defective in ymr1∆ 
yeast cells, which lacks the myotubularin (MTMR)-type phosphatase gene YMR1 [61]. In 
sharp contrast, in mammals, PtdIns(3)P phosphatases Jumpy (MTMR14), MTMR3, and 
the MTMR8–MTMR9 complex (see below) negatively regulate autophagy, indicating a 
positive correlation between the PtdIns(3)P amount on the autophagosome and autoph-
agy activity [62–64]. This difference in the distribution of PtdIns(3)P may reflect the ne-
cessity of PtdIns(3)P for the downstream pathway during autophagy, i.e., in mammals, 
there might be more downstream PtdIns(3)P-binding effectors than in yeast. Alterna-
tively, in mammals, the PtdIns(3)P generated on the autophagosome might be more read-
ily used as a precursor for other phosphoinositides (also see Section 8). 
Regulation of intracellular PtdIns(3)P concentration appears to be important for hu-
man health. Myotubularins comprise 15 members, MTM1 and MTMRs 1–14. Among 
them, 9 members are catalytically active and dephosphorylate PtdIns(3)P and 
PtdIns(3,5)P2 to convert them to PtdIns and PtdIns(5)P, respectively. Some myotubularins 
are essential for the maintenance of muscles [65,66], and mutations in them are associated 
with neuromuscular diseases. Mutations in the MTM1 gene caused a severe form of X-
linked congenital myopathy [67]. Also, mutations in the MTM2 gene were found in Char-
cot–Marie–Tooth disease [68]. PtdIns(3)P levels were increased in the mtm1 null murine 
muscle [69] and in HeLa cells treated with siRNA to deplete MTM1 [70]. Also, muscles 
from Mtm1-null mice showed increased autophagic activity [71]. The Mtm1 KO mouse 
phenotype was rescued by muscle-specific ablation of Pik3c2b, the class II PI3K, which 
also contributes to PtdIns(3)P production (see Section 1 and Figure 1) [9,72]. The same 
study also showed that the mtm1 phenotype in zebrafish was rescued by PtdIns(3)P in-
hibitor treatments [72]. In addition, defects in cells from cross-linked centronuclear myo-
pathy patients could be partially rescued by treatment with a PtdIns(3)P inhibitor [70]. 
These observations indicate that excessive PtdIns(3)P, in addition to insufficient 
PtdIns(3)P, are both toxic to the cell. Interestingly, conditional knockout mice lacking 
Vps15 in skeletal muscles also showed a severe myopathy [57]. Intracellular PtdIns(3)P 
concentration appears to be tightly regulated to not be too high or too low. 
5. Regulation of VPS34/Vps34 Complex Activity by Phosphorylation from Upstream 
Regulators, the ULK1 Complex and mTORC1 
Both in yeast and metazoans, complex I activity is regulated by various upstream 
regulators. The ULK1/Atg1 complex and the mTOR/TOR complex (mammals/yeast) are 
two of the best-characterized regulators. ULK1/Atg1 and mTOR/TOR are serine/threonine 
kinases that phosphorylate autophagy-related (ATG/Atg) proteins including the complex 
I subunits to activate or inhibit the initiation step of autophagy [73,74] (Figure 4A). Alt-
hough there are many more upstream regulators [35], including AMPK1 [75,76] and Akt 
[77], this section focuses on these two regulators. 




Figure 4. VPS34 complex regulation by the ULK1 complex and mTORC1. (A) The ULK1 complex acts as a positive regu-
lator of complex I during starvation, whereas mTORC1 acts as a negative regulator in nutrient-replete conditions. Their 
phosphorylation positions are indicated in the schematic structure of complex I. Green dots: activating phosphorylation 
by the ULK1 complex; red dots: inhibiting phosphorylation by mTORC1. (B) Left: VPS34 (or, putatively, complex II) acts 
as a positive regulator of mTORC1 in amino acid-replete conditions. Amino acids activate VPS34 to synthesize PtdIns(3)P, 
which activates PLD1. Phosphatidic acid (PA), the PLD1 product, binds to mTOR to activate it. Right: After long-term 
starvation, lysosomes are regenerated by autophagic lysosomal regulation (ALR). Then, accumulated autophagy sub-
strates in autolysosomes are degraded, and amino acids are regenerated. This activates mTORC1 to phosphorylate 
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which the tubulated autolysosome is detached by dynamin. (C) VPS34–mTORC1 activation by lysosome translocation. 
VPS34 (potentially complex II) is activated by amino acids to synthesize PtdIns(3)P, which is bound by FYCO1 via its 
FYVE domain. This also causes lysosome translocation to the cell periphery via the microtubule–kinesin–FYCO1 interac-
tion. At the plasma membrane, mTORC1 is in close proximity to nutrient-signalling complexes to become activated. 
5.1. Complex I Regulation by Phosphorylation from the ULK1/Atg1 Complex 
Macroautophagy (hereafter autophagy) is triggered by various starvation conditions. 
Autophagy comprises several steps, the first of which is initiation, followed by nucleation, 
during which PtdIns(3)P made by complex I, potentially on the ER, recruits downstream 
effectors such as DFCP1 and WIPIs (see Section 8). This nucleates isolation membranes, 
or phagophores. Isolation membranes are then expanded and closed to become an au-
tophagosome. The autophagosome is fused with lysosomes to become autolysosomes, af-
ter which the internal cargos or substrates are degraded to regenerate amino acids, lipids, 
and nucleic acids. 
The ULK1/Atg1 complex is essential for the initiation of all types of canonical au-
tophagy. The ULK1/Atg1 is composed of ULK1-FIP200-ATG101-ATG13 for mammals and 
Atg1-Atg13-Atg17-Atg29-Atg31 for yeast [78]. It is genetically located at the most up-
stream point of a hierarchy of ATG/Atg proteins that gives rise to the preautophagosomal 
structure or the phagophore assembly site (PAS) [79,80]. In the absence of the ULK1/Atg1 
complex, complex I cannot be recruited to the PAS [80,81]. Although this complex I re-
cruitment mechanism is still not fully understood, ULK1 phosphorylation on complex I 
subunits during autophagy has been associated to this process. Remarkably, all of the 
complex I and II subunits have been reported to be phosphorylated by ULK1 [73,82–84], 
indicating the importance of ULK1 on the regulation of complex I activity. Russell et al. 
found that the S15 residue of Beclin1 (note that the original paper reported this as S14) 
was phosphorylated by ULK1, and that this phosphorylation was critical for autophagy 
induction by amino acid starvation [82]. Also, the authors showed that S15 phosphoryla-
tion was promoted by either ATG14L or UVRAG [82]. The S30 residue on Beclin1 was also 
reported to be phosphorylated by ULK1 during amino acid starvation and hypoxia [83]. 
While this phosphorylation was promoted by ATG14L, it was not by UVRAG [83]. Yeast 
Vps30 was found to be phosphorylated by Atg1 [85,86], specifically at S85 [85], although 
its role has not been characterized. On the complex I-specific ATG14L subunit, S29 phos-
phorylation by the ULK1 complex was increased by starvation and mTOR inactivation 
[84]. This phosphorylation was important for the synthesis of PtdIns(3)P and initiation of 
autophagy, but not for the maturation step [84]. On VPS34, the S249 residue was shown 
to be phosphorylated by ULK1, although neither phosphomimetic nor nonphosphorylata-
ble mutants significantly affected autophagy [87]. On the complex I-specific fifth subunit 
NRBF2/Atg38 (see Section 9), multiple serine residues (S96, S103, S109, and S133) on Atg38 
were found to be phosphorylated by Atg1, although the role(s) of the phosphorylation on 
these residues have not been characterized [85]. Also, NRBF2 was phosphorylated by 
ULK1, although the exact site of this phosphorylation is not clear [88]. Lastly, a recent 
unbiased phosphoproteomics study in search of ULK1 and ULK2 substrates using SILAC 
and tandem mass tag (TMT) found six phosphorylation sites on VPS15 (S813, S861, S865, 
S879, S1039, and S1289) [89]. Mutations of these residues affected autophagy and PI3K 
activities in vivo and in vitro, with S861 playing the main role among the six phosphory-
lation sites [89]. The same study also found that UVRAG was phosphorylated by ULK1, 
though the exact amino acid residue and its role remain to be seen [89]. 
Understandably, the phosphorylation of each subunit/residue was characterized in-
dividually and separately. However, the phosphorylation by ULK1/Atg1 on all subunits 
should take place at the same time in the cell. This could be a reason why the single S249 
mutation on VPS34 did not show a significant effect. With the availability of information 
on the ULK1 phosphorylation of all individual complex I and II subunits, it will be inter-
esting to examine the effect of the sum or synergy of the phosphorylations on the whole 
complexes in vitro. One technical difficulty for in vitro experiments is that overexpression 
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of full-length ULK1 causes toxicity to the cell [90–92]. Therefore, the insect cell-expressed 
soluble ULK1 kinase domain, which is also toxic when expressed in bacteria [93], has been 
used for in vitro ULK1 kinase assays. This may lack the substrate recognition domain/mo-
tif(s) of ULK1 and may result in less specific substrate recognition, as regulatory subunits 
of the ULK1 complex (FIP200 or ATG13) have roles in specifying substrates. For instance, 
the lack of ATG13 or FIP200 abolished the S30 phosphorylation of Beclin1 [83] and S29 
phosphorylation of ATG14L [84]. Immunoprecipitated endogenous ULK1 complex has 
also been used for the ULK1 kinase assays, as it can eliminate the problem described 
above. However, the protein identities of the immunoprecipitants are less clear, and ef-
fects from contaminated proteins cannot be excluded. It appears that coexpression of 
ULK1-ATG101-ATG13 in mammalian suspension cells can overcome this problem [94]. 
Also, full-length yeast Atg1 alone can be expressed in insect cells and reconstituted with 
Atg13 and the Atg17 complex [95–97]. These may be useful solutions for designing more 
precise experiments. 
The potential effect of the ULK1 phosphorylation on the complex I subunits might be 
conformational changes and/or an increase in local charge, which may lead to direct in-
teraction with the ULK1 complex or other proteins or complexes. For example, immuno-
precipitation studies detected an interaction between mammalian ATG13 and ATG14L 
[84,98], whereas in yeast this interaction was not detected [99]. 
5.2. mTORC1–VPS34 and VPS34–mTORC1 Pathways 
Autophagy induction by rapamycin was originally shown for yeast [100]. Later, this 
mechanism was found to be conserved through evolution [101–103]. Rapamycin inacti-
vates mechanistic/mammalian target of rapamycin (mTOR), or TOR in yeast, which mim-
ics starvation conditions to trigger autophagy. mTOR serves as a hub in the nutrient sig-
nalling network. It can be found in two mutually exclusive complexes, mTORC1 and 
mTORC2, which are composed of mTOR-Raptor-mLst8 and mTOR-Protor-Rictor-mSin1-
mLst8, respectively. mTORC1 is acutely inactivated by rapamycin [104,105], whereas the 
effect of rapamycin on mTORC2 is dependent on cell line, tissue, and duration of treat-
ment [106,107]. mTOR is activated by amino acids, growth factors, and insulin to phos-
phorylate various substrates [108]. In particular, mTORC1 phosphorylates autophagy-re-
lated proteins to inactivate them in rich-medium conditions [74,109]. The formation of the 
yeast Atg1 complex is prevented by TORC1 in rich medium by hyperphosphorylation of 
Atg13 [110,111], which impairs PAS formation. On the other hand, the formation of the 
mammalian ULK1 complex is not affected by nutrient condition [101], although ATG13 is 
similarly phosphorylated by mTOR in nutrient-rich conditions as the yeast Atg13 by TOR 
[76,101]. Whereas the ULK1 complex negatively regulates mTORC1 activity [112]. Thus, 
two upstream autophagy regulators, the ULK1/Atg1 complex and the mTOR/TOR com-
plex 1, mutually regulate each other (Figure 4A). 
Interestingly, among the complex I and II subunits, only the complex-specific subu-
nits (ATG14L, NRBF2, and UVRAG) have been found to be phosphorylated by mTORC1. 
Multiple serine/threonine residues in ATG14L were found to be phosphorylated by 
mTOR, and mutating these residues into alanines increased PI3K and autophagy activity 
[113]. The mTOR phosphorylation of complex I-specific NRBF2 on the S113 and S120 res-
idues leads NRBF2 to bind to VPS34–VPS15 subunits and inactivate the complex [88]. In 
sharp contrast, an in vitro study showed that bacterially purified, PTM-free NRBF2 bound 
to VPS15 to activate complex I [114]. Reconciling these opposite results remains to be done 
in the future. On the other hand, dephosphorylation of these residues upon starvation 
rearranges the NRBF2–complex I interaction into an NRBF2–Beclin1–ATG14L interaction 
in the complex, in turn activating the complex [88]. Three serine residues in complex II-
specific UVRAG are known to be phosphorylated by mTOR: S498, S550, and S571. S498 
phosphorylation increases the association with Rubicon, the fifth subunit of complex II 
(see Section 9). This leads to a decrease in VPS34 activity and, consequently, inhibition of 
endosome and autophagosome maturation steps [115]. On the other hand, S550 and S571 
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phosphorylation increase complex II activity [116]. Moreover, this activation is required 
for the scission step of lysosomal tubulation during autophagosome–lysosome refor-
mation (ALR) [116,117] (see Figure 4B for more details). All of these serine residues are 
located in the metazoan-specific C-terminal domain of UVRAG (CTD, Figures 2 and 4B). 
Because structural information is not available for this region, the mechanisms of these 
inhibition/activation events remain to be seen. Similarly as for ULK1 phosphorylation, the 
sum or synergy of the mTOR phosphorylation on all complex I and II subunits will reveal 
more detailed mechanisms for the activation and conformational changes of the com-
plexes. 
VPS34 is known to increase mTOR activity. This is mainly based on the findings that 
amino acids or insulin increased VPS34 activity, which was followed by an increase in 
mTOR activity [118–120], and the findings that mTOR was activated by phosphatidic acid 
(PA) [121–123], which is synthesised by phospholipase D (PLD) from phosphatidylcholine 
(PC, Figure 4B). PLDs possess a PX domain that binds to PtdIns(3)P (for more details on 
the PX domain, see Section 8.3). PtdIns(3)P increased PLD1 activity via its PX domain 
[124]. In addition, mice with defects in the Mtm1 gene, the product of which removes the 
phosphate from PtdIns(3)P, showed hyperactivation of mTOR [125] (see Section 4). An 
NMR study showed that PA bound to the FRB domain of mTOR [126]. Based on the struc-
tures of mTORC1 in complexes with RagA/C heterodimers, and with the small G-protein 
RHEB, it was proposed that the FRB domain is located distantly from the membrane, 
where PA is situated [127]. One possibility is that PA may also bind to some other re-
gion(s) of mTORC1. Alternatively, mTORC1 may undergo conformational changes to 
bind to PA. Also, Raptor binds to PLD2 via the TOS-like motif on PLD2 [128]. This amino 
acid-stimulated VPS34–mTOR activation was found to be mediated by leucyl-tRNA syn-
thase (LRS) in the presence of leucine [129]. LRS binds to VPS34 in vivo, which facilitates 
VPS34 activation [129] (Figure 4B). 
Another proposal about mTOR activation by VPS34 is that the PtdIns(3)P-binding 
FYCO1 translocates the mTORC1-carrying lysosomes to the cell periphery to facilitate 
mTOR activation [130] (see Figure 4C for more details). 
In contrast, when human skeletal muscle cells were serum starved, then subse-
quently serum recovered, VPS34 inhibition did not prevent mTOR activity [131]. Also, in 
steady-state mouse embryonic fibroblasts (MEFs), Vps34 deficiency did not affect mTOR 
activity, but Vps34 was essential for acute mTOR activation [132]. This indicates that 
mTOR activation by VPS34/PtdIns(3)P might be dependent on cell type or growth condi-
tion. 
6. Genetic and Cell Biological Hierarchy of the Recruitment of Complex I at the Initia-
tion Step of Autophagy 
As described above, the ULK1/Atg1 complex is an essential upstream regulator for 
complex I and for the initiation of autophagy. An ultrastructural analysis showed that 
isolation membranes could not be formed in FIP200 KO or ATG9 KO MEFs, and that in 
HeLa cells treated with a PI3K inhibitor, wortmannin, the selective autophagy substrate 
p62 was aggregated, and unknown small vesicles were clustered at the autophagosome 
formation site [81]. This indicates that the ULK1 complex I, ATG9, and PtdIns(3)P (com-
plex I) are essential for the initiation of autophagy. Several hierarchical analyses of these 
three components have revealed that the ULK1 complex and ATG9 are essential for the 
localization of ATG14L (and hence complex I) [80,81]. The ULK1 complex targets some 
ER-related membranes other than ATG9 vesicles independently of PtdIns(3)P, since the 
ULK1 complex subunits can associate with membranes in the absence of ATG9 [53]. In 
addition, ULK1 can target p62 in ATG9 KO MEFs [81]. Membrane associations of the 
ULK1 complex subunits and ATG9 are independent of ATG14L [53]. FIP200, an ULK1 
complex subunit, tethers the other ULK1 component to membranes independently of 
ATG9 and PtdIns(3)P [53,81], and ATG9 association with membranes and p62 is also in-
dependent of the ULK1 complex and PtdIns(3)P [81]. These observations suggest that the 
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ULK1 complex and ATG9 are upstream of complex I, and that the ULK1 complex and 
ATG9 may contribute in parallel to the initiation step. Similarly, in yeast, Atg11 and 
Atg17, which are the Atg1 complex subunits with scaffolding roles, are at the most up-
stream end of the hierarchy [79]. Although FIP200 was initially proposed as the Atg17 
orthologue [92], structurally, Atg11 is closer to FIP200 [133]. Also, Atg9 is at the upstream 
of yeast complex I [79]. During Parkin-mediated mitophagy, the ULK1 complex and ATG9 
target depolarized mitochondria independently, and a similar hierarchical recruitment of 
the downstream ATG proteins was reported [134]. Emerging evidence has suggested that 
the ULK1 complex targets two distinct membranes: ER membranes and ATG9 vesicles. 
PtdIns(3)P is required for the translocation of the ULK1 complex to ATG9-positive mem-
branes [53]. Also, upon treatment by wortmannin, the lifespan and size of ATG13-positive 
puncta become shorter and smaller, respectively [135]. These results indicate that alt-
hough PtdIns(3)P/complex I is dispensable for the initial localization of the ULK1 complex 
and ATG9, it may become important for maintaining the ULK1 complex on membranes 
to create a positive feedback loop and for proceeding to downstream steps of autophagy. 
It remains to be seen how PtdIns(3)P or complex I can contribute to the maintenance mech-
anism of the ULK1 complex. 
7. Lipid Environments That Influence the VPS34/Vps34 Complex Activities 
7.1. Physicochemical Parameters That Affect the VPS34/Vps34 Activities 
Because phospholipids are major constituents for biological membranes, they are the 
focus here. A lipid molecule is composed of a polar head, a backbone (glycerol or sphin-
gosine), and fatty acids or acyl chains (Figure 5A). The polar head is composed of an alco-
hol moiety and a phosphate, and the alcohol substituent defines the lipid species, such as 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), and 
PtdIns. Polar heads face towards the aqueous side in a lipid bilayer and thus have a role 
in binding to lipid-specific binding proteins. For instance, the polar heads of PS and phos-
phoinositides are negatively charged. Therefore, they can attract various positively 
charged proteins or protein patches (see below). Despite the fact that lipids are constantly 
trafficked and shuffled among membrane compartments, each organelle has a relatively 
unique lipid composition represented by polar heads [136,137]. Also, acyl chain properties 
are tissue- and organelle-specific and greatly influence protein–membrane interactions 
[138–140]. Collectively, there are three important physicochemical parameters of a mem-
brane that can affect membrane–protein interaction and lipid kinase/phosphatase activi-
ties: lipid packing of acyl chains, membrane curvature, and electrostatics of polar heads 
as represented by PS and phosphoinositides [140] (Figure 5B), which are explained below 
in greater detail. 




Figure 5. Physicochemical parameters that affect activities and membrane binding of autophagy-related proteins. (A) A 
schematic structure of a phospholipid molecule. A phospholipid is composed of a polar head comprising a modified al-
cohol (R) and a phosphate, a backbone (glycerol here, also can be sphingosine), and fatty acids or acyl chains. R in the 
polar head defines the lipid species, such as serine for PS, ethanolamine for PE, choline for PC, and inositol for PtdIns. The 
polar head and backbone constitute hydrophilic head, facing the aqueous side of the membrane, whereas the acyl chains 
provide a hydrophobic barrier. (B) Three important physicochemical parameters that affect activities and membrane as-
sociations of autophagy-related proteins: packing, membrane curvature, and electrostatics. 
7.2. Lipid Packing of Acyl Chains 
The length and saturation status of acyl chains are key determinants to characterize 
biological membranes [141,142] (Figure 4B). Double bonds in acyl chains introduce kinks 
in the chains (Figure 5A), causing lipid-packing defects (Figure 5B). Packing defects pro-
vide more space in the lipid bilayer, which makes the membrane more flexible. Also, be-
cause of the parallel arrangement of the sn-1 and sn-2 chains, ether (alkyl) chains cause 
tighter packing [143,144]. Ether lipids constitute about 20% of the total phospholipids in 
mammals, and they can be found in various tissues and organs. Another important pack-
ing factor is cholesterol (ergosterols in yeast) and sphingomyelin [145,146], which are 
abundant in the plasma membrane (PM) and endosomal membranes, making them 
thicker and less elastic. This property is particularly important for the PM, given that it 
serves as the boundary between the cell and outside. 
The amphipathic-lipid-packing-sensor (ALPS) motif serves as a packing sensor. This 
motif was first identified in ARFGAP1 [147]. It has the property of forming an amphi-
pathic alpha-helical structure, with its polar face weakly charged mainly by serine and 
threonine residues [148]. With these Ser/Thr residues, ALPS and ALPS-like motifs recog-
nize membrane curvature [148]. Hydrophobic residues of ALPS motifs are inserted into 
loosely packed membrane surfaces, but they seem to be insensitive to electrostatics be-
cause of the lack of basic residues [148]. Indeed, the ALPS motif in the ATG14L BATS 
domain (Figure 2A,B) serves as a packing sensor of VPS34 complex I [26]. Packing defects 
can also be caused by membrane thinning in an artificial membrane system in which the 
ArfGAP1 ALPS motif is recruited to the thinned area [149]. 
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In the cell, membrane curvature can be generated either spontaneously or by protein 
domains or motifs (Figure 5B). Spontaneous membrane curvature can be caused by noncy-
lindrical lipids. For instance, because relative volumes of the polar heads of PE, PA, car-
diolipin (CL), and diacylglycerol (DAG) are smaller than their acyl chains, these lipids are 
inverted cone-shaped, generating negative curvature into membranes. Conversely, rela-
tive volumes of polar heads in lysophospholipids are larger; therefore, they are cone-
shaped, resulting in positive curvature in membranes [150–152]. In regard to protein-gen-
erated curvature, some amphipathic helices (e.g., alfa-synuclein and Sar1), and C2 do-
mains (e.g., Synaptotagmin) insert into membranes to generate membrane curvature [152–
155]. In endocytic pathways, where the lipid composition is similar to that of PM mem-
branes and more tightly packed and less flexible than that of ER membranes [156,157], 
curvature is generated by several representative proteins, such as sorting nexin (SNX), 
and endophilin proteins that have BAR domains [158–161]. In contrast to the ALPS motif, 
BAR domains not only sense membrane curvature but generate and enhance it (Figure 
5B) [162–164]. This is due to the facts that the membrane-associating regions of the BAR 
domains are composed of basic amino acids and that endocytic membranes are more 
abundant with PS than ER membranes, in which PS is mostly found on the luminal side 
[140]. In addition, BAR domain-containing proteins also tend to form oligomers [152,162]. 
Charge-driven interaction is not in common with the ALPS motif [140]. A recent study 
also suggested that protein phase separation can cause membrane bending or curvature 
[165]. 
7.4. Electrostatics from PS 
PS is a major phospholipid, accounting for ~10% of total biological membranes 
[166,167]. The negatively charged property of PS can attract various positively charged 
protein patches to enhance protein–membrane interactions and can activate various pro-
tein/lipid kinases/phosphatases both in vitro and in vivo [168–172]. PS is synthesized in 
the ER and mitochondria-associated membranes (MAM, Figure 6), from which PS is trans-
ferred throughout the cell via vesicle trafficking or PS-specific lipid transfer proteins [167]. 
The ER and mitochondria have low levels of PS (~4% and ~1%, respectively), and they are 
rarely colocalized with the PS binding probe, Lact-C2 [173], indicating that PS is localized 
at the luminal side of the ER. This ER-localized PS is used mainly as a precursor to syn-
thesize phosphatidylethanolamine (PE) [174]. In contrast, PS is asymmetrically enriched 
in the cytoplasmic leaflet of the plasma membrane (PM); therefore, many PS-binding pro-
teins are also PM-associating proteins [174]. 
7.5. The Use and Interpretation of High-Percentage PS In Vitro 
A high concentration of PS could cause an artificial effect in vitro. For example, we 
recently showed that not only human VPS34 complexes I and II but even VPS34 alone 
could be greatly activated on giant unilamellar vesicles (GUVs) containing 25% DOPS 
compared with 10% DOPS-containing GUVs [24]. This condition was purposefully de-
signed to see an exaggerated effect of electrostatics on lipid kinase activities in vitro. As 
mentioned below (see Section 7.7), PS can be locally enriched in ER membranes, where 
complex I is recruited during starvation, and has an important role on early endosomes 
[157], to which complex II and its recruiting protein Rab5 are mainly localized, but it re-
mains elusive whether this activation by 25% DOPS could be physiological or not. In par-
ticular, VPS34 alone lacks the membrane-associating adaptor arm (Figure 2B) and was 
inactive on 10% DOPS-containing GUVs. Nonetheless, it could be activated by high-PS-
containing lipids [24]. Therefore, the VPS34 result may be interpreted as an artificial effect. 
For performing in vitro liposome experiments, it is noteworthy that commercially availa-
ble lipid substrates are mostly designed for selecting strong inhibitors as part of a drug 
screen. Therefore, they are designed to maximize activity and made of only PtdIns or sim-
ple mixtures of PtdIns and PS at the ratios of 1:9 (PV5122, Thermo Fisher) or 1:3 (V1711, 
Promega), at which the PS concentrations are extremely high. When researchers plan to 
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measure physiologically relevant lipid kinase activities or membrane binding, it is highly 
recommended to make liposomes of which the lipid composition mimics that of the orga-
nelle of interest. Recently published guidelines described the experimental design in more 
detail [175]. To examine the effect of PS on the interaction or activation of the protein of 
interest in vitro, it is also advisable to colocalize the protein of interest with a PS marker 
or binding probe such as Lact-C2 [176,177] in cells in advance. This may ensure the phys-
iological correlation between the localization of the protein of interest and PS. 
7.6. Electrostatics from Phosphoinositides 
As mentioned in the introduction, there are seven possible phosphoinositides de-
pending on the position and the number of phosphates on the inositol ring. Because of the 
negatively charged property of the phosphate group(s), phosphoinositides can provide 
membranes with electrostatics. Similarly to PS, this can attract phosphoinositide-binding 
proteins with clusters of basic residues such as actin regulatory proteins [178]. Although 
this may lead to the assumption that the order of binding strength or activity of phospho-
inositide-binding proteins should be PtdIns(3,4,5)P3 > biphosphates > monophosphates, 
this was not the case, at least with human VPS34 complexes I and II [24]. It appears that 
the protein–phosphoinositide interaction might be regulated by either stereochemistry, 
the net charge of the phospholipid (i.e., the number of phosphates on the inositol ring), or 
the balance between these factors [179–181]. 
7.7. Physicochemical Properties of Autophagosomal Membranes 
In mammals, autophagy appears to be initiated at multiple sites on ER membranes 
[182–185]. ER membranes are composed of unsaturated lipids with shorter acyl chains 
and less phosphatidylserine (PS) and cholesterol than plasma membrane lipids, which are 
composed of more saturated lipids with longer acyl chains and higher levels of PS and 
sterols [140,186]. This ER lipid property results in flexible and highly curved membranes 
that may be able to attract various packing-sensing proteins. Indeed, the yeast Atg1 initi-
ation complex prefers highly curved membranes to bind to [97,187]. In particular, highly 
curved membrane structures called omegasomes are a hallmark of initiation/nucleation 
of autophagy in mammalian cells (Figure 6) [183]. It is not clear whether omegasome for-
mation is promoted by ATG proteins or ATG proteins use the already formed ome-
gasome. The omegasome is marked by the PtdIns(3)P-binding protein DFCP1, indicating 
that complex I and PtdIns(3)P effectors prefer highly curved membranes to associate with 
(also see Section 8). As mentioned above, PS is not abundant in ER membranes. However, 
during starvation, phosphatidylserine synthase 1 (PSS1), which synthesizes PS from phos-
phatidylcholine (PC), is colocalized with FIP200 independently of PtdIns(3)P [53]. PSS1 is 
localized mainly to MAM [188], wherein ATG14L was also found to be recruited during 
starvation (Figure 6) [189]. This indicates that even if the average PS concentrations in the 
cytoplasmic side of the ER and mitochondria are low, it may be possible to increase the 
local PS concentration in a continuous membrane during starvation. Although it remains 
to be seen, this locally increased PS may be used to attract various proteins such as the 
ULK1/Atg1 complex to initiate autophagy. Taken together, these ER membrane proper-
ties—flexible, highly curved, and locally enriched with PS during starvation—may con-
stitute an ideal platform to initiate autophagy. After initiation, further membrane curva-
ture is generated. Although the protein identities for this role have not been revealed in 
mammals [190], in yeast, the sorting nexin Atg20–Atg24 (Snx4) heterodimer, which is 
known to be on the PAS [191] and is downstream of Vps34 [192], can cause membrane 
tubulation [193]. Also, a lipidated form of the yeast Atg8 was recently found to have a 
membrane deformation role [194] (Figure 6). These findings suggest that the physico-
chemical properties of membranes are important determinants for the formation of the 
autophagosome [195]. The following examples of in vitro studies indicate that three phys-
icochemical properties—lipid saturation, packing, and electrostatics—greatly affect the 
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activities and membrane binding of ATG/Atg proteins and VPS34 complex I, as summa-
rized in Table 1. 
 
Figure 6. Summary of membrane/lipid environments that are targeted by autophagy-related proteins. During starvation, 
PtdIns is synthesized in the ER by PIS, which is targeted by the ULK1 complex and essential for the generation of the 
autophagosome. Complex I, the ATG16–ATG12–ATG5 complex, and the ATG2/Atg2–WIPI4/Atg18 complex prefer un-
saturated (unpacked) and highly curved membranes for their activations. ER membranes and ATG9/Atg9 vesicles fulfil 
these conditions. During expansion, phagophores are tethered and fused, which is facilitated by Atg8 family proteins. 
Also, curvatures are generated at least by the lipidated yeast Atg8, and the yeast Atg20–Atg24 complex might detect and 
stabilize membrane curvatures at the edge of the expanding phagophore to support expansion. Along with this, upon 
starvation, PS synthesis occurs at the ER–mitochondria contact site by PSS1, which is targeted by the ULK1 and complex 
I. This may also lead to the initiation of autophagosome formation. 
Table 1. Summary of effects of lipid physicochemical parameters on the activities and membrane binding of autophagy-
related proteins. The lipid physicochemical parameters of ATG9/Atg9 vesicles are also involved. 
Protein (Complex)  Packing Curvature Electrostatics Reference 
Atg1 complex binding 
to membranes 
Not known Binds more strongly 
to smaller vesicles 
PS concentration did not 
affect membrane binding 
of Atg1 and Atg13, 
PtdIns(3)P increased 





High unsaturated lipids 
(yeast) 
High curvature (30–60 
nm) 
<10% PS (yeast) [81,196,197] 
Human VPS34 com-
plexes I and II 
More active on GUVs com-
posed of unsaturated lipids 
More active on 
smaller vesicles, BATS 
domain binds to 
smaller vesicles more 
strongly 
More active with higher 






brane binding (MB), 
tethering (MT), and li-
pid transfer (LT) 
Atg2 recognizes packing 
defects and binds to smaller 
vesicles. LT and MT by 
ATG2A–WIPI4 with DO 
Stronger MB, MT, and 
LT on smaller vesicles 
(ATG2A/B/Atg2) 
PS and PtdIns(3)P in-
crease MB, MT, and LT of 
ATG2A and ATG2B, 
whereas they decrease 
[198–202] 
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(18:1–18:1) lipids are more 
efficient than PO (16:0–18:1) 
lipids 
MT and LT activity of 
Atg2 
LC3B/Atg8 lipidation 
More efficient on GUVs 
with DO (18:1–18:1) lipids 
than those with PO (16:0–
18:1) lipids (LC3B) 
Possible with Atg12–
Atg5 on SUVs, re-
quires Atg16–Atg12–
Atg5 on GUVs (Atg8) 
Not known [203,204] 
Membrane tethering 
and fusion by GATE-16 
and GABARAP 
Not known 
Smaller vesicles, CL 
and DAG facilitate fu-
sion 
Not known [205] 
Tethering comparison 
between LC3B and 
GATE-16 
Not known 
LC3B > GATE-16 on 
50 nm vesicles, GATE-
16 > LC3B on 200–400 
nm vesicles 
Not known [206] 
7.8. Effects of Lipid Packing, Curvature, and Electrostatics on the Activity and Membrane 
Binding of VPS34 Complexes 
Because VPS34/Vps34 is a lipid kinase, lipid environments greatly affect the activity 
and membrane binding of VPS34/Vps34 complexes. As briefly mentioned in Section 3, this 
phenomenon is mediated by specific motifs in the complexes. The membrane binding and 
activity of human complex I depends on the ALPS motif in the BATS domain of ATG14L 
[24,26,28,140]. The ATG14L ALPS motif senses membrane curvature, with preference for 
small vesicles or high membrane curvature [26]. It must be noted that yeast Atg14 does 
not have the BATS domain; therefore, yeast complex I activity is much lower than yeast 
complex II activity in vitro on flat membranes [23]. Nonetheless, yeast Atg14 shows clear 
PAS localization in the cell [207,208]. It remains unclear how the yeast complex I is re-
cruited to and becomes activated on the PAS. The membrane binding and activity of hu-
man complex II depend on two aromatic finger motifs (aromatic fingers 1 and 2) and the 
hydrophobic loop, all of which are in the BARA domain of Beclin 1 [24,30] (Figure 2B). In 
the yeast complex II, only the aromatic finger 1 motif was found to be responsible for 
membrane binding and activity [23]. The activities of both human complexes are greatly 
influenced by membrane packing. With increasing lipid saturation, both human com-
plexes become less active [24]. This packing effect was found both with nonsubstrate li-
pids and with the substrate PtdIns [24]. Interestingly, this packing effect was partially 
compensated by membrane curvature, i.e., the complexes still showed some activities on 
smaller vesicles composed of half-saturated lipids [24]. Also as mentioned above, electro-
statics represented by PS greatly influence the activity of both complexes, although exper-
iments on this topic need to be carefully planned and interpreted. 
7.9. Effects of Packing, Membrane Curvature, and Electrostatics on Membrane Tethering (MT) 
and Lipid Transfer (LT) of ATG2A/B/Atg2 
Within 30 min after starvation induction, autophagosomes with sizes around 400–
900 nm/500–1500 nm (yeast/mammals) are generated to engulf cargos [209,210]. This 
means that large amounts of lipids have to be promptly provided to form the double-
layered autophagosomal membranes. Lipid-transfer proteins ATG2A and B in mammals 
and Atg2 in yeast regulate this process at the downstream of complex I [79,81,211]. Recent 
cellular, in vitro, and structural studies have revealed that these proteins have activities 
of membrane tethering (MT) and lipid transfer (LT) bipartitely, so that lipids can be trans-
ferred from the membrane source(s), which is/are likely the ER or ATG9/Atg9 vesicles, to 
the isolation membrane or phagophore [197–199,212–214]. This process is facilitated by 
the VPS34/Vps34 effector proteins, WIPIs/Atg18 [200–202,211,215]. ATG2A/B has the 
strongest affinity to WIPI4 [216], whereas the Atg2–Atg18 interaction is weak [202]. be-
cause of their involvement in LT, the effects of the three physicochemical parameters—
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packing, membrane curvature, and electrostatics—on MT and LT activities have been in-
tensively characterized (Table 1). The yeast Atg2 is known to recognize packing defects 
[199]. Also, the LT of ATG2A–WIPI4 is more efficient with small unilamellar vesicles 
(SUVs) composed of DO (18:1–18:1) lipids than with PO (16:0–18:1) SUVs [200]. All of 
ATG2A/B/Atg2 prefer smaller vesicles for their membrane binding, MT, and LT 
[200,202,215]. High PS concentrations enhance the membrane binding, MT, and LT of 
ATG2A [200] and the MT and LT of ATG2B [202]. The MT and LT of ATG2B can be also 
enhanced by PtdIns(3)P [202]. This high PS can bypass the necessity of WIPI4 for the MT 
and LT of ATG2A/B [200,216]. On the other hand, the MT and LT of the yeast Atg2 in the 
absence of Atg18 (see below) is decreased by high PS and PtdIns(3)P [202], indicating that 
while their MT and LT activities are conserved through evolution, detailed mechanisms 
might be differently regulated. Notably, the yeast Atg2 without Atg18 can activate MT 
and LT in vitro [202,215], whereas in the cell, functional Atg18 is required for the localiza-
tion of Atg2 to autophagic membranes [79,217]. It remains to be seen which step or path-
way these in vitro MT/LT activities of Atg2 without Atg18 reflect. 
7.10. Roles of Lipid Unpacking and Curvature on the Atg16/ATG16L Complex and the 
Lipidation of Atg8 Families 
The ubiquitin-like Atg8 family proteins (Atg8 in yeast and LC3/GABARAP proteins 
in mammals) are among the core ATG/Atg proteins. Unlike ubiquitins, they are lipidated 
by PE, and these lipidated forms are essential for autophagosome biogenesis. The human 
ATG16L complex, which is an E3-like enzyme composed of ATG12-ATG5-ATG16L, can 
specify the LC3 lipidation membrane for autophagosome biogenesis by recruiting LC3 
[218]. This lipidation is dependent on the E2-like ATG3/Atg3. In yeast, the PAS localiza-
tion of the Atg16 complex and Atg3 is Vps34 complex I-dependent [219], indicating that 
PtdIns(3)P synthesis on the PAS is essential for the recruitment of downstream factors 
[79,80]. In vitro studies suggested that LC3 recruitment to the membrane and its lipidation 
are also greatly affected by lipid physicochemical parameters. On SUVs, yeast Atg8 lipi-
dation occurs only with Atg12–Atg5, whereas on GUVs, Atg16 is required for efficient 
Atg8 lipidation [204]. Furthermore, the LC3B lipidation by the mammalian ATG16 com-
plex occurs more efficiently on GUVs composed of DO (18:1–18:1) lipids than on GUVs 
composed of PO (16:0–18:1) lipids [203], indicating that both membrane curvature (vesicle 
size) and packing are critical factors for the lipidation of Atg8 family proteins. The lipi-
dated forms of the human Atg8 family proteins GATE-16 and GABARAP promote mem-
brane tethering and fusion. In particular, vesicle diameter and negative intrinsic curva-
ture-inducing lipids (cardiolipin (CL) and diacylglycerol (DAG)) (Figure 4B) facilitate fu-
sion events [205]. Even among the human Atg8 family proteins, it appears that each pro-
tein has its own curvature preference, since LC3B can tether SUVs more efficiently than 
GATE-16, whereas GATE-16 can tether LUVs more efficiently than LC3B [206]. In line 
with cell biological observations [220,221], these in vitro findings suggest that each of the 
human Atg8 family proteins may have a unique role at a different stage of autophagosome 
biogenesis by targeting a membrane with a different physicochemical property. Further-
more, a recent study revealed that the physiologically lipidated form of yeast Atg8 could 
induce positive membrane curvature in vitro [194]. 
7.11. Phosphatidylinositol (PtdIns), the Sole Substrate for VPS34/Vps34 
PtdIns makes up 10–15% of the total lipids in mammalian cells [222]. Because 
VPS34/Vps34 uses PtdIns as a sole substrate, the localization of PtdIns is equally im-
portant as the intracellular localization of VPS34 complexes. For example, although the 
cytoplasmic leaflet of the plasma membrane (PM) is abundant with PS [174], which greatly 
activates both complexes I and II (see Section 7.4) [24], PtdIns(3)P is rarely observed there. 
This could be partly due to very low levels of PtdIns at the PM (see below) [223,224] and 
tight lipid packing in PM membranes [140,174], where VPS34/Vps34 are not active [24] 
(see Section 7.8). 
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PtdIns is synthesized by PI synthase (PIS) from cytidine diphosphate-diacylglycerol 
(CDP-DG) and inositol in the ER (Figure 6) [225]. Except for plants, most eukaryotes ex-
press a single PIS gene [225,226]. PIS is an ER-localized transmembrane protein. Upon 
starvation, the ULK1 complex is recruited to PIS-positive structures, which do not colo-
calize with ERGIC and ER exit markers or mitochondria [53]. The PtdIns synthesis at the 
PIS-positive structures is necessary for the recruitment of the ULK1 complex and the fol-
lowing formation of the isolation membrane [53]. This indicates that PtdIns has a greater 
role in the formation of autophagosomes than as a substrate for VPS34. In yeast, the rela-
tive PtdIns content in whole cell membranes was increased by starvation from 12 to 46% 
[227]. Also, acyl chain profiles of phospholipids were shifted to longer and more unsatu-
rated [227]. This indicates that during starvation, intracellular phospholipid composition 
can be dramatically rearranged. The same study also measured the phospholipid compo-
sition of autophagosomes by immunoisolating Atg8-containing vesicles and found 37% 
of PtdIns. Also, around 60% of phospholipids had two unsaturated acyl chains [227]. 
These results indicate that the high PtdIns content and unsaturated acyl chain property 
are key features of yeast autophagosomes. The lipid composition in autophagic mem-
branes might be different in organisms. In Drosophila autophagosomes that were im-
munoisolated by Atg8a, the PtdIns concentration was around 10%, and phosphatidyleth-
anolamine (PE) was the major component in the wildtype animals, whereas the PtdIns 
concentration was dramatically increased in autophagosomes from Atg2− flies [228]. Sim-
ilarly to the case of yeast, over 60% of Drosophila autophagic membranes were unsaturated 
[228]. The high abundance of unsaturated lipids is a common feature of autophagosomal 
membranes at least between yeast and flies, although this approach cannot exclude the 
possibility that measurement of the lipid compositions also includes engulfed membranes 
inside autophagosomes. 
PtdIns is also known to be abundant in yeast Atg9 vesicles, in which PtdIns makes 
up over 40% of the vesicle lipids [197]. Both in yeast and mammals, ATG9/Atg9 vesicles 
are 30–60 nm in diameter [81,196] (Table 1) and derived from the Golgi [196,229–231]. 
Because human ATG9 vesicles do not contain PIS [53], the PtdIns in ATG9 vesicles might 
be synthesized elsewhere. Since PtdIns is enriched in the Golgi (see below), it appears that 
ATG9 vesicles might bud off from PtdIns-concentrated regions in Golgi membranes, alt-
hough the mechanism for this remains to be seen. Human complex I has a binding pref-
erence for PtdIns compared with complex II [28]. As mentioned above, human complex I 
is more reactive to unsaturated PtdIns than saturated PtdIns, and both human complexes 
I and II are more reactive to membranes composed of unsaturated nonsubstrate lipids 
(also see above) [24,232]. Collectively, high-PtdIns-containing, highly curved (small), and 
unsaturated (flexible) membranes with Rab1/Ypt1 (see Section 3.2) of ATG9/Atg9 vesicles 
can be ideal platforms for complex I to activate during autophagy. 
Except for the autophagosome and the ER, from which PtdIns is distributed through-
out the cell, exact intracellular localization of PtdIns has been enigmatic. While subcellular 
fractionation followed by lipid mass spectrometry can provide quantitative information 
on lipid species, including acyl chain length and saturation, it lacks the topology infor-
mation. Also, because organelle membranes are to some extent interconnective, it is tech-
nically difficult to resolve each organelle fraction and to fractionate membrane contact 
sites between organelles. Recently developed methods from two groups to detect intra-
cellular PtdIns may complement these approaches [223,224]. These include a PtdIns-spe-
cific binding probe, BcPI-PLCH82A, and indirect monitoring of diacylglycerol (DAG), a con-
verted product from PtdIns by PI-PLC on specified organelles. These studies agreed well 
on high PtdIns abundance in the Golgi and low abundance in the PM [223,224]. Interest-
ingly, although PtdIns(3)P is well known to be enriched in early endosomes, in which an 
early endosomal small GTPase Rab5 recruits complex II [31,43–45] (Figure 3B, also see 
Section 8), BcPI-PLCH82A could not be found in either early or late endosomes [223]. Endo-
somal PtdIns(3)P production was greatly affected by the ER-residing PtdIns [223], indi-
cating that the endosomal PtdIns could potentially be provided from the ER rather than 
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through de novo synthesis at endosomes. This may be achieved by the direct connection 
between the ER and endosomes [233,234]. An alternative hypothesis could be that PtdIns-
specific lipid transfer proteins (LTPs) may directly provide PtdIns to complex II [235], alt-
hough this is unlikely given that the heterotetramer complex II requires a membrane plat-
form to activate [23,24]. Although BcPI-PLCH82A could not detect PtdIns in late endosomes, 
there was an indication of PtdIns existing there [223]. Because endosomes are enriched 
with phosphoinositide phosphatases [236], one possibility is that some monophospho-
inositides might be quickly converted back to PtdIns alongside direct PtdIns transfer from 
the ER (also see Section 8.3). 
7.12. Membrane Properties in Health and Disease 
In actual human bodies, lipid compositions differ between sexes and between aged 
and young populations [237]. For example, alkyl (ether) and saturated forms of phospho-
lipids are increased in older populations compared with younger populations [237]. Also, 
changes in lipid compositions have been found in various diseases, including a rare neu-
rometabolic syndrome (Sjögren–Larsson syndrome (SLS)) [238] and various types of can-
cer [239]. Changes in PtdIns properties have been associated with human health and dis-
eases. In mammalian cells, PtdIns is selectively enriched with stearic acid (C18:0) at the 
sn-1 position and arachidonic acid (C20:4) at the sn-2 position, designated as 38:4 or SAPI. 
This occupies up to 30–85% of total PtdIns species depending on the tissue and cell type 
[225]. A metastasis-promoting mutation in p53 (Trp53R172H) [240] increased the level of 
18:1–18:1 PtdIns (dioleoyl PI, or DOPI) in mouse pancreas and MEFs [241]. Also, an in-
creased level of the wildtype p53 was associated with a shift in phospholipids, especially 
PtdIns, from having two monounsaturated acyl chains to having one or no monounsatu-
rated acyl chains [242]. These studies indicate that p53 may repress the unsaturation of 
acyl chains, which could be an important part of supressing tumorigenesis. Human VPS34 
complex I is activated more strongly by DOPI than SAPI [24]. Therefore, it is likely that in 
p53-dysfunctional cells, VPS34 complexes might be more active. In aggressive cancerous 
prostate tissues, an increased proportion of PtdIns with 0–2 double bond-containing acyl 
chains in relation to that with ≥3 double bond-containing acyl chains was found [243]. 
Also, in B16 cells, 38:4 PtdIns was greatly reduced by heat shock and benzyl alcohol (BA), 
a membrane fluidizer [244]. These findings indicate that even if the genes encoding VPS34 
complex subunits are not mutated, the activity of the complexes can be greatly influenced 
by surrounding environments that affect lipid compositions. 
8. VPS34 Activation Regulation by Feedback Mechanisms and Downstream Effectors 
8.1. Autophagy 
The PtdIns(3)P produced by complex I during autophagy recruits downstream effec-
tors such as WIPIs and DFCP1, which leads to nucleation of phagophores [80,245] (Figure 
6). The WD-repeat proteins interacting with phosphoinositides (WIPIs) or PROPPINs are 
the only known PtdIns(3)P-binding effectors that are essential for autophagy and con-
served from yeast to mammals. Humans have four WIPIs (WIPI1 to WIPI4), and yeasts 
have three, Atg18, Atg21, and Hsv2. They fold as seven-bladed β-propellers [246–248] and 
bind to both PtdIns(3)P and PtdIns(3,5)P2 with blades 5 and 6 [247]. For the membrane 
localization of WIPIs, PtdIns(3)P is essential for both yeast and mammals [80,217]. WIPIs 
bind to ATG2A/Atg2 [200,201,216,217,249] (see Section 7.9) and ATG16 L1 [203,250] sepa-
rately. In each case, the WIPI facilitates or enhances the function of the binding protein or 
protein complex [200,203]. Fracchiolla et al. reported that LC3B lipidation by the ATG12–
ATG5–ATG16L1 complex was enhanced by WIPI2d. Furthermore, the same study found 
that VPS34 complex I activity was enhanced by WIPI2d, which led to positive feedback 
on PtdIns(3)P synthesis [203] (Figure 7A). Interestingly, Birgisdottir et al. found several 
LC3 interacting regions (LIRs) in the subunits of human VPS34 complex I, and the Atg8 
family proteins GABARAP and GABARAPL1 preferably bound to VPS34 complex I [251]. 
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Although the consequence of the interaction between the Atg8 family proteins and VPS34 
complex I remains to be seen, one may hypothesize that there could be another positive 
feedback loop between VPS34 complex I and Atg8 family proteins to enhance PtdIns(3)P 
synthesis and the lipidation of Atg8 family proteins (Figure 7A). 
 
Figure 7. Positive PtdIns(3)P feedback mechanisms via complexes I (A) and II (B). (A) Complex I is activated by its effector 
WIPI2d, which leads to a positive feedback loop of PtdIns(3)P synthesis. WIPI2d also facilitates the LC3B lipidation by 
interacting with the ATG12–ATG5–ATG16L E3 complex. GABARAP and GABARAPL1, Atg8 family proteins, are known 
to preferably interact with complex I, but the consequence of this interaction remains to be seen. (B) On early endosomes, 
Rab5 interacts with its GEF-effector complex, the Rabex5–Rabaptin5 complex. This interaction switches the Rab5 nucleo-
tide binding from GDP to GTP and its binding partner from Rabex5 to Rabaptin5. This interaction causes the formation of 
Rab5 domain (clustering), which is enhanced by PtdIns(3)P, indicating positive feedback between Rab5–Rabex5–Rabap-
tin5 and complex II. These Rab5- and PtdIns(3)P-enriched clusters recruit more Rab5 effectors and PtdIns(3)P-binding 
proteins carrying PX and FYVE domains. 
8.2. Endocytic Pathway 
Unlike autophagy, the endocytic pathway is branched into multiple pathways with 
various membranous compartments. These endosomal compartments are sorted in a va-
riety of ways, and their membranes undergo a variety of membrane trafficking and defor-
mations, including tubulation, fission/scission, tethering, and fusion. These are vital for 
receptor and ion channel recycling, formation of multivesicular bodies (MBVs), and en-
dosome maturation from early to late endosomes [252–254]. PtdIns(3)P is essential for the 
majority of these events. Also, while much receptor-mediated signal transduction takes 
place at the plasma membrane, early endosomes can also be a platform for some signalling 
molecules. 
As described in Section 3.2, complex II is recruited and activated by Rab5 on early 
endosomes [31,44,45,255], where PtdIns(3)P is produced and used as a signalling molecule 
for downstream effectors (Figure 3B). The activity and patterns of cellular localization of 
small GTPases are coupled with their interactions with GEFs and effectors. In the case of 
Rab5, the Rabex5–Rabaptin5 complex is its GEF-effector complex [156,256,257], and this 
Rab5–GEF-effector interaction enhances the domain formation on membranes [156]. This 
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feedback loop between PtdIns(3)P synthesis and the Rab5–GEF-effector complex, poten-
tially via PtdIns(3)P binding to the hypervariable region of Rab5 [258]. The locally con-
centrated Rab5 may recruit its effectors to activate their downstream pathways. This pos-
itive feedback mechanism is reminiscent of the positive feedback in the complex I–WIPIs–
ATG16 complex during autophagy (Figure 7). 
8.3. PtdIns(3)P-Binding Proteins in Endocytic Pathways 
In endocytic pathways, there are a variety of PtdIns(3)P-binding proteins that typi-
cally carry the PX or FYVE domains [259–261]. Although more protein domains have been 
reported to bind to PtdIns(3)P [262], I focus on these two domains. While both of them 
have a binding specificity for PtdIns(3)P, their structures and PtdIns(3)P binding mecha-
nisms are different [263]. For example, while the PtdIns(3)P binding of the FYVE domains 
is pH sensitive [264,265], PX domains bind to PtdIns(3)P independently of pH [265]. 
A representative protein family for PX domain-carrying proteins is the large sorting 
nexins (SNXs) family [266]. They can be found as parts of protein complexes such as the 
retromer and retriever complexes that are involved in recycling receptor proteins 
[266,267]. In addition, many SNXs have BAR domains that are involved in membrane tu-
bulation/deformation (see Section 7.3). Therefore, the PX-BAR-containing SNXs deform 
membranes into tubules in a PtdIns(3)P-dependent manner [268]. The PtdIns(3)P-binding 
PX domains have been also found in other proteins, including a SNARE protein, 
Vam7/VAMP7 (yeast/mammals), which is involved in membrane fusion [269]; phospho-
lipase Ds (PLDs) that produce phosphatidic acid (PA) and soluble choline from phospha-
tidylcholine [270] (also see Section 5.2 and Figure 4B); and pPhoX40, a member of the Phox 
complex, a phagocytic NADPH oxidase complex [271]. Another enzyme with a PX do-
main is the serum and glucocorticoid-regulated kinase3 (SGK3), a serine/threonine kinase 
that acts at the downstream of the class I PI3K–PDK1 signalling independently of AKT 
[272,273]. The PtdIns(3)P binding via its PX domain is important for the activation SGK3 
itself [274,275]. The existence of these PtdIns(3)P-binding PX domains in a wide range of 
intracellular pathways reflects the importance of VPS34 and PtdIns(3)P for cellular home-
ostasis. 
The FYVE domain was named after the proteins Fab1, YOTB, Vac1, and EEA1. Com-
pared with PX domains, it appears that FYVE domains are more specialized for PtdIns(3)P 
binding [260]. FYVE-containing proteins tend to homodimerize, which enhances the af-
finity to PtdIns(3)P [260]. By using this characteristic, the Stenmark laboratory developed 
the 2xFYVE reporter, wherein two mouse HRS FYVE domains were tandemly arranged. 
This greatly enhanced the PtdIns(3)P binding compared with the single FYVE domain and 
has been widely used for monitoring intracellular PtdIns(3)P localization [255]. Similarly 
to PX domains, FYVE domain-containing proteins can be found in a variety of cellular 
events. EEA1 is a Rab5 effector and tethers homotypic early endosomes [276–278]. As 
mentioned above, VPS34 complex II is also a Rab5 effector, indicating that Rab5 serves as 
a hub wherein its effectors and effector’s product further interact to enhance downstream 
events (Figure 7B). Other protein examples that contain the FYVE domain include RUFY 
family proteins, DFCP1, and SARA. The recently redefined RUFY (Run and FYVE do-
main-containing) family proteins are found in endocytic pathways, phagocytosis, and au-
tophagy [279]. DFCP1 is found in the cis-Golgi during rich-medium conditions, then 
translocated to the omegasome, the hallmark structure of autophagosome initiation/nu-
cleation (Figure 6) [183]. Smad anchor for receptor activation (SARA) is involved in TGF-
beta-induced Smad2 nuclear localization [280,281]. Importantly, FYVE domains are also 
found in phosphatidylinositol-3 phosphatases (MTMRs), which dephosphorylate 
PtdIns(3)P to synthesize PtdIns (also see Section 4), and in phosphatidylinositol 3-phos-
phate 5-kinase Fab1/PIKFyve (yeast/mammals), which phosphorylate the 5′-OH position 
of PtdIns(3)P to synthesize PtdIns(3,5)P2 [282,283]. This indicates that unlike that in au-
tophagy, PtdIns(3)P in endocytic pathways is used as a precursor for PtdIns and 
PtdIns(3,5)P2. Because MTMRs and Fab1/PIKFyve are found mainly in late endosomes, 
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PtdIns(3)P is less abundant there than in early endosomes, although it is still essential for 
the maintenance of late endosomes, since the lack of VPS34/Vps34 causes a loss of mul-
tivesicular bodies (MVBs) [255,284,285] (also see Section 7.11). 
9. Regulation of VPS34 Activation by Binding Proteins 
As mentioned above, interactions with Rab1a and Rab5a greatly increase the activi-
ties of complex I and complex II, respectively [31,45]. Other well-known VPS34 complex-
binding proteins are the fifth subunits of the complexes, NRBF2/Atg38 (mammals/yeast) 
for complex I and Rubicon for complex II. Unlike the Rab proteins, the interactions of 
which with the complexes are very weak and transient, the interactions between the fifth 
subunit and the complex are strong, and the pentameric complexes can be purified 
through size exclusion chromatography [29,48,55,114]. On the other hand, their roles in 
the activity of the complexes are controversial. While it is agreed that the complex I-spe-
cific NRBF2/Atg38 is found on the autophagosome, it has been reported both as a positive 
and a negative regulator of complex I (see review [34]; also see Section 5). Also, the exact 
binding subunit(s) of complex I for NRBF2/Atg38 and binding stoichiometry between 
complex I and NRBF2/Atg38 remain to be elucidated [34]. Autophagy and in vitro studies 
have agreed that Rubicon is a negative regulator of autophagy and complex II [20,29]. 
However, during LC3-associated phagocytosis (LAP), a noncanonical autophagy, Rubi-
con acts as a positive regulator of complex II [286]. Rubicon is also known to bind to Rab7 
via its C-terminal Rubicon homology (RH) domain [287,288], whereas it has been also re-
ported that Rab7 also binds to VPS15 [289]. Another study showed that Rab7 competed 
with UVRAG, the complex II-specific subunit for the Rubicon binding [290]. It remains to 
be seen how these Rab7 interactions with Rubicon and VPS15 (potentially complex II) take 
place. 
In addition, a variety of proteins, including Ambra1 [291], PAQR3 [292], GO-
RASP2/GRASP55 [293], PDPK1 [294], and SH3GLB1/Bif-1 [295], have been found to inter-
act with the VPS34 complex subunits. Because most of these interactions were examined 
by immunoprecipitation or yeast two-hybrid assays, most of their direct interactions with 
and direct involvements in the activation of VPS34 complexes remain to be seen. For ex-
ample, although Ambra1 was found as a Beclin 1-interacting protein in 2007 [291], the 
complex specificity of Ambra1 has been still elusive. Also, Ambra1 pulldown could not 
detect Sypro Ruby-visible Beclin 1 [296], indicating that the interaction was very weak or 
indirect. In contrast, GAPR-1/GLIPR2, which was found as an interacting protein of the 
Tat-beclin1 peptide [297,298] (see below), was recently found to bind to purified VPS34 
complex I, negatively regulate VPS34 complex I activity, and serve as a negative regulator 
of autophagy [298]. Also, it has been reported that Beclin 1 binds to the HIV-1 Nef, an 
antiautophagic maturation protein, via a region containing the β1-β2 ß1–ß2 strands in the 
Beclin 1 BARA domain [297,299]. In addition, an in vitro study showed that HIV-1 Nef 
inhibited complex II activity [29]. By using this HIV-1 Nef–Beclin 1 interaction, a fusion 
peptide between a Beclin 1 BARA domain fragment and a cell-permeable peptide derived 
from the HIV-1 Tat protein transduction domain, the Tat-beclin1 peptide, was designed 
as an autophagy activator and indeed increased autophagic activity [297]. Because VPS34 
and Beclin 1 are shared between complexes I and II, inhibitors or activators targeting these 
subunits affect the activity of both complexes. To overcome this, Wu et al. engineered the 
coiled-coil domain of UVRAG to enhance its binding to the Beclin 1 coiled-coil domain 
and to outcompete with ATG14L and Beclin 1 self-dimerization [300]. The same study also 
designed a “stapled” peptide to promote the interaction between the Beclin 1 coiled-coil 
domain and the coiled-coil domain of UVRAG or ATG14L as well as to reduce Beclin 1 
dimerization [300]. Finally, although it is not a protein, a screen to find small molecules 
that selectively inhibit the formation of complex I was recently developed and resulted in 
the successful discovery of a compound [301]. 
10. Concluding Remarks and Future Perspectives 
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Recent progress in cryo-EM and cryotomography, and in other biophysical tech-
niques such as HDX-MS and single molecule kinetics, has helped understand the detailed 
activation mechanisms of VPS34/Vps34 complexes. These approaches have revealed that 
the kinase domain of VPS34/Vps34 is not the sole activation determinant of activity. In-
stead, activity is greatly influenced by the binding subunits of the complexes, lipid envi-
ronments, and accessory regulatory proteins. Therefore, in some human diseases, where 
the above influencing factors are altered, it might be possible that the VPS34 activity is 
significantly altered even though the genes encoding the VPS34 complex subunits are not 
mutated. To examine this, developing a quantitative, physiologically relevant, and handy 
method to measure VPS34 activity in vivo as well as in vitro is essential. In the cell, since 
the PtdIns(3)P-driven signalling in autophagy and endocytic pathways is regulated spa-
tially and temporally, it is conceivable that VPS34/Vps34 complexes may interact with 
their binding proteins and membranes only transiently, as the cases of the complex I–
Rab1a and complex II–Rab5a interactions. Methods to precisely screen these weak and 
transient interactions such as BioID will be powerful tools for the future proteomics of 
VPS34 complexes. Lastly, this knowledge on activation mechanisms can be applied to 
translational efforts to develop more specific activators and inhibitors for the treatment of 
human diseases. 
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